2/23
12:32 pm
vir
Rating for VIR
Low
Report
Rating for VIR
1/29
07:28 am
vir
Vir Biotechnology, Inc. (NASDAQ: VIR) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $9.00 price target on the stock, down previously from $23.00.
Medium
Report
Vir Biotechnology, Inc. (NASDAQ: VIR) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $9.00 price target on the stock, down previously from $23.00.
1/29
06:04 am
vir
Rating for VIR
Low
Report
Rating for VIR